Biopharma Quarterly Dealmaking Statistics, Q1 2015
A look at financing, M&A, and alliance activity January–March 2015
Executive Summary
Biopharma financing reached $15.1 billion, with record-breaking FOPO dollar volume making up close to $10 billion of the total; AbbVie topped the $66.5 billion M&A activity with its $20 billion buy of Pharmacyclics; and gastroenterology was one of the most highly partnered therapeutic areas.